-+ 0.00%
-+ 0.00%
-+ 0.00%

RADIOPHARM THERANOSTICS - SCHEDULES END-OF-PHASE 2 FDA MEETING FOR RAD101 PHASE 3 TRIAL ON OCT 1, 2026

Reuters·08/17/2026 11:30:00

Please log in to view news